Motilent Limited
Private Limited Company · London
ActiveUnited KingdomIncorporated 2013Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-03-31
IXBRL · 147 source facts · 28 selected values
Validation findingsXBRL valid
Accounts to 2025-03-31
IXBRL · 147 source facts · 28 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-04-01 to 2025-03-31
- Extraction status
- complete
- Numeric facts
- 77
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2025-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2512_08730130_20250331
- Source archive
- Accounts_Monthly_Data-December2025.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-03-31
IXBRL · 131 source facts · 28 selected values
Not assessedlegacy record
Accounts to 2024-03-31
IXBRL · 131 source facts · 28 selected values
Not assessed
legacy record
- Reporting period
- 2023-04-01 to 2024-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 68
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_3200_08730130_20240331
- Source archive
- Accounts_Monthly_Data-December2024.zip
Accounts to 2023-03-31
IXBRL · 128 source facts · 28 selected values
Not assessedlegacy record
Accounts to 2023-03-31
IXBRL · 128 source facts · 28 selected values
Not assessed
legacy record
- Reporting period
- 2022-04-01 to 2023-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 68
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_6666_08730130_20230331
- Source archive
- Accounts_Monthly_Data-December2023.zip
Accounts to 2022-03-31
IXBRL · 123 source facts · 26 selected values
Not assessedlegacy record
Accounts to 2022-03-31
IXBRL · 123 source facts · 26 selected values
Not assessed
legacy record
- Reporting period
- 2021-04-01 to 2022-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 66
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0002_08730130_20220331
- Source archive
- Accounts_Monthly_Data-December2022.zip
Accounts to 2021-03-31
IXBRL · 121 source facts · 25 selected values
Not assessedlegacy record
Accounts to 2021-03-31
IXBRL · 121 source facts · 25 selected values
Not assessed
legacy record
- Reporting period
- 2020-04-01 to 2021-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 64
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0098_08730130_20210331
- Source archive
- Accounts_Monthly_Data-December2021.zip
Accounts to 2020-03-31
IXBRL · 43 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2020-03-31
IXBRL · 43 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2018-11-01 to 2020-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 16
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0088_08730130_20200331
- Source archive
- Accounts_Monthly_Data-March2021.zip
Accounts to 2018-10-31
IXBRL · 43 source facts · 16 selected values
Not assessedlegacy record
Accounts to 2018-10-31
IXBRL · 43 source facts · 16 selected values
Not assessed
legacy record
- Reporting period
- 2017-11-01 to 2018-10-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 16
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0068_08730130_20181031
- Source archive
- Accounts_Monthly_Data-July2019.zip
Accounts to 2017-10-31
IXBRL · 34 source facts · 9 selected values
Not assessedlegacy record
Accounts to 2017-10-31
IXBRL · 34 source facts · 9 selected values
Not assessed
legacy record
- Reporting period
- 2016-11-01 to 2017-10-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 9
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0056_08730130_20171031
- Source archive
- Accounts_Monthly_Data-July2018.zip
Accounts to 2016-10-31
IXBRL · 48 source facts · 12 selected values
Not assessedlegacy record
Accounts to 2016-10-31
IXBRL · 48 source facts · 12 selected values
Not assessed
legacy record
- Reporting period
- 2015-11-01 to 2016-10-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 20
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0044_08730130_20161031
- Source archive
- Accounts_Monthly_Data-July2017.zip
Accounts to 2015-10-31
IXBRL · 44 source facts · 18 selected values
Not assessedlegacy record
Accounts to 2015-10-31
IXBRL · 44 source facts · 18 selected values
Not assessed
legacy record
- Reporting period
- 2014-11-01 to 2015-10-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 28
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0032_08730130_20151031
- Source archive
- Accounts_Monthly_Data-July2016.zip
Accounts to 2014-10-31
IXBRL · 25 source facts · 7 selected values
Not assessedlegacy record
Accounts to 2014-10-31
IXBRL · 25 source facts · 7 selected values
Not assessed
legacy record
- Reporting period
- 2013-10-14 to 2014-10-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 9
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0020_08730130_20141031
- Source archive
- Accounts_Monthly_Data-July2015.zip
Registered details
08730130- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2013-10-14
- Jurisdiction
- —
- Registered office
- BEYOND ALDGATE TOWER, 2 LEMAN STREET, LONDON, E1 8FA, UNITED KINGDOM
Classification
1 SIC codes23103
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
12 matched grantsSynthetic hEalthcare dAta goveRnanCe HubLeadLive
Innovate UK · EU-Funded · 2024-10-01 – 2028-09-30
£486,861
awarded
Synthetic hEalthcare dAta goveRnanCe HubActive
Horizon Europe Guarantee · EU-Funded · 2024-09-30 – 2028-09-29
£486,861
whole project
Synthetic hEalthcare dAta goveRnanCe HubLeadActive
Horizon Europe Guarantee · EU-Funded · 2024-09-30 – 2028-09-29
£486,861
whole project
Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseasesLeadLive
Innovate UK · EU-Funded · 2023-04-01 – 2028-03-31
£263,610
awarded
Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseasesActive
Horizon Europe Guarantee · EU-Funded · 2023-03-31 – 2028-03-30
£263,610
whole project
Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseasesLeadActive
Horizon Europe Guarantee · EU-Funded · 2023-03-31 – 2028-03-30
£263,610
whole project
Realising the potential of open MRI for dynamic studies of human anatomy and functionEPSRC · Research Grant · 2021-03-31 – 2024-11-30 · with 9 other participants£848,532whole project
Realising the potential of open MRI for dynamic studies of human anatomy and function
EPSRC · Research Grant · 2021-03-31 – 2024-11-30 · with 9 other participants
£848,532
whole project
University Of NottinghamleadASG SuperconductorsColoplastDerby Teaching Hospitals NHS Foundation TrustLeo Cancer CareMinistry of Defence (MoD)Motilent LimitedUniversity College LondonUniversity Of OxfordUniversity of Sheffield
Quantitative Reporting in Crohn’s Disease: Maximising available MRI data to better direct patient treatment, speed up treatment decisions and improve healthcare outcomesLead
Innovate UK · Feasibility Studies · 2020-06-01 – 2020-11-30
£182,000
awarded
Quantitative Reporting in Crohn’s Disease: Maximising available MRI data to better direct patient treatment, speed up treatment decisions and improve healthcare outcomesLeadInnovate UK · Collaborative R&D · 2020-04-01 – 2023-03-31 · with 3 other participants£989,649awarded
Quantitative Reporting in Crohn’s Disease: Maximising available MRI data to better direct patient treatment, speed up treatment decisions and improve healthcare outcomesLead
Innovate UK · Collaborative R&D · 2020-04-01 – 2023-03-31 · with 3 other participants
£989,649
awarded
Motilent Limitedlead£989,649
Nottingham University Hospitals NHS Trust£136,514
Great Ormond Street Hospital£59,360
Quantitative Reporting in Crohn’s Disease: Maximising available MRI data to better direct patient treatment, speed up treatment decisions and improve healthcare outcomesISCF · Collaborative R&D · 2020-03-31 – 2023-03-30 · with 3 other participants£1,574,005whole project
Quantitative Reporting in Crohn’s Disease: Maximising available MRI data to better direct patient treatment, speed up treatment decisions and improve healthcare outcomes
ISCF · Collaborative R&D · 2020-03-31 – 2023-03-30 · with 3 other participants
£1,574,005
whole project
Motilent LimitedleadGreat Ormond Street HospitalNottingham University Hospitals NHS TrustUniversity College London
Quantitative Reporting in Crohn’s Disease: Maximising available MRI data to better direct patient treatment, speed up treatment decisions and improve healthcare outcomesLeadISCF · Collaborative R&D · 2020-03-31 – 2023-03-30 · with 3 other participants£1,574,005whole project
Quantitative Reporting in Crohn’s Disease: Maximising available MRI data to better direct patient treatment, speed up treatment decisions and improve healthcare outcomesLead
ISCF · Collaborative R&D · 2020-03-31 – 2023-03-30 · with 3 other participants
£1,574,005
whole project
Motilent LimitedleadGreat Ormond Street HospitalNottingham University Hospitals NHS TrustUniversity College London
Innovative Technologies for Stratified and Experimental MedicineMRC · Research Grant · 2015-03-31 – 2016-03-30 · with 16 other participants£14,621,436whole project
Innovative Technologies for Stratified and Experimental Medicine
MRC · Research Grant · 2015-03-31 – 2016-03-30 · with 16 other participants
£14,621,436
whole project
University Of CambridgeleadEli Lilly & Company LtdGE Healthcare LimitedImperial College LondonLgc LtdLudwig Maximilian University of Munich (LMU Munich)Mercodia ABMotilent LtdSiemens AGSiemens HealthcareUniversity of AdelaideUniversity of BaselUniversity of California, San FranciscoUniversity of CambridgeUniversity Of EdinburghUniversity Of NottinghamUniversity of Warwick